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Objective. To compare maternal morbidity in HIV-infected and uninfected pregnant women. Methods.Major maternal morbidity
(severe febrile illness, illnesses requiring hospital admissions, surgical revisions, or illnesses resulting in death) was measured
prospectively in a cohort of HIV-infected and uninfected women followed from 36 weeks of pregnancy to 6 weeks after delivery.
Odds ratios of major morbidity and associated factors were examined using logistic regression. Results. Major morbidity was
observed in 46/129 (36%) and 104/390 (27%) of the HIV-infected and HIV-uninfected women, respectively, who remained in
followup. In the multivariable analysis, major morbidity was independently associated with HIV infection, adjusted odds ratio
(AOR) 1.7 (1.1 to 2.7), nulliparity (AOR 2.0 (1.3 to 3.0)), and lack of, or minimal, formal education (AOR 2.1 (1.1 to 3.8)).
Conclusions. HIV was associated with a 70% increase in the odds of major maternal morbidity in these Ugandan mothers.
1.Introduction
Maternal morbidity is deﬁned as illness in a woman who was
or is pregnant from any cause related to the pregnancy, abor-
tion, or child birth, excluding incidental or accidental causes
[1]. In Uganda, the true level of maternal morbidity is un-
known, but national estimates suggest that 5.1 maternal
deaths occur for every 1,000 live births [2]. Although there
has been a decline in maternal mortality since 2000 [3],
childbearingisstillassociated withsigniﬁcantmorbidityand
mortality in this country. Like most sub-Saharan countries,
Uganda has experienced a heavy burden of HIV-related
disease in the last few decades. In men and non-pregnant
women, HIV has been associated with at least a 2-fold
increase in morbidity [4, 5] and 10–20-fold increase in
mortality [6,7]. Less is known about the association between
HIV and maternal morbidity. We undertook a prospec-
tive observational study to describe, estimate, and compare
the risk of maternal morbidity in HIV-infected and unin-
fected women in Uganda.
2.Methods
2.1. Setting. The study was conducted at St. Raphael of St.
Francis Hospital Nsambya, in Kampala, Uganda, between
November2002and November2003.Thehospitalisacatho-
lic missionary hospital located in the capital city (Kampala).
During the study year, there were a total of 24,461 antenatal
visits (of whom 6,016 were new bookings) and 10,768 deliv-
eriesrecorded.The hospitalprovidedcare togeneralandpri-
vatepatientswho paidattotalofabout$10(general)and$40
(private) for antenatal care and a normal vaginal delivery.
This hospital was one of the pilot sites for the Ugan-
dan national programme to prevent mother-to-child HIV
transmission (PMTCT) and the main source of antenatal,2 Journal of Pregnancy
intrapartum and postnatal care for the local population [8].
During the study period all women attending the hospital
for antenatal care were oﬀered free opt-in HIV testing and
counselling. Women were classiﬁed as HIV-infected if they
had two positive rapid tests. HIV-infected women were given
modiﬁed intrapartum obstetric care by delaying the rupture
ofmembranes and avoidingepisiotomies when possible. The
main PMTCT regimen oﬀered to women at the time was
zidovudine monotherapy from 36 weeks of pregnancy to
1 week after delivery or a single dose of nevirapine given
to HIV-infected women at the onset of labour. The use of
highly active antiretroviral therapy (HAART) in pregnancy
was not yet widely implemented. Exclusivebreastfeeding was
encouraged for both HIV-infected and uninfected mothers,
but infected mothers could also give replacement feeds if
after assessment this mode of feeding was deemed feasible.
2.2. Study Design. Pregnant women with known HIV status
and willing to participate in the study were recruited into
a prospective cohort at about 36 weeks of pregnancy and
followed up until six weeks after the delivery. As maternal
morbidity is known to be associated with parity [9], the
cohort was restricted to nulliparous (para 0) and uniparous
(para 1) women. HIV-infected and uninfected mothers were
recruited in the ratio of 1 to 3. The main exposure of interest
was the woman’s HIV status and the primary outcome was
any observed or self-reported major maternal morbidity. A
woman was classiﬁed as having major maternal morbidity
if she experienced one or more of the following: illness
leading to hospital admission, severe febrile illness (fever
lasting 3 days or longer), surgical revisions of abdominal or
perineal wounds due to wound breakdown, and any illnesses
that resulted in death. These maternal conditions have been
classiﬁed as major morbidity by other authors [10–12].
Baseline data including demographic characteristics (na-
tionality, residence, and age), socioeconomic confounders
(education, marital status, and employment), medical his-
tory, and obstetric history were collected by interview in
the antenatal clinic at 36–40 weeks of pregnancy using a
semistructured questionnaire. CD4 tests were oﬀered to
HIV-infected women at baseline and analysed using rou-
tine standard laboratory procedures. Delivery data were
abstracted from hospital records. A second interview was
held six weeks after delivery for women to report on
their morbidity during the study period. Women who did
not attend the hospital for delivery and/or the 6 weeks
postpartum appointment were telephoned and/or visited at
home immediately after the missed hospital appointment.
The data were analysed using SPSS 11.5. Characteristics
of HIV-infected and uninfected women were compared
using either binary measures (percentages or odds ratios)
where statistical signiﬁcance of diﬀerences was examined
with chi-squared test statistics, or means where diﬀerences
were compared using F or t test statistics. In addition, CD4
measures were summarised using medians and interquartile
ranges (IQR). Fisher’s exact test was used when expected
values in contingency table cells were less than 5, and Yates’
correction was applied to chi-square tests on 2 × 2t a b l e s .
Odds ratios were ﬁrst estimated crudely, without adjustment
for potential confounders and then with adjustment for
confounders (adjusted odds ratios, AOR) using logistic
regression models.
The study was approved in the UK by the Oxfordshire
Tropical Research Ethics Committee (OXTREC) and in
Uganda by the National AIDS Research Ethics Committee,
the National Council of Science and Technology, and St.
Raphael of St. Francis Hospital Nsambya administration.
3.Results
The characteristics of the 132 HIV-infected women and
399 HIV-uninfected women recruited into the cohort over
the 12 month study period are summarized in Table 1.
There were statistically signiﬁcant diﬀerences between HIV-
infected and uninfected women in parity, mean gestational
age at recruitment, education, and infant feeding practices
(Table1).ThemajorityoftheHIV-infectedwomen(100/132,
76%) were classiﬁed as asymptomatic (WHO stage 1). In
106 (80%) of HIV-infected women for whom CD4 counts at
36–40 weeks of pregnancy were available, the median CD4
count was 350/uL, (IQR 221 to 552/uL); 71 (67%) of the
women had CD4 count >200/uL.PMTCT regimendata were
available for 125 HIV infected women and the majority took
monotherapy with AZT74 (59%) or Nevirapine 48 (38.4%).
Only 3(2.4%)were onHAARTand excludingthemfromthe
analysis had no signiﬁcant impact on the results.
At 6 weeks after delivery, follow-up data was available
for 129/132 (97%) HIV-infected and 389/399 (97%) HIV
uninfected women. Of these women, 46/129 (36%) who
were HIV-infected, and 104/390 (27%) who were uninfected
reported major morbidity. The crude odds ratio for any
major morbidity in HIV-infected women compared to unin-
fectedwomenwas1.52(95%conﬁdenceinterval0.97to2.38,
P = 0.05).Theconditionsthatcontributedtomajor morbid-
ity are shown in Table 2. Two of the 6 hospital admissions
among HIV-infected women occurred before delivery and
were due to severe malaria. The remaining four admissions
occurring after delivery were reported as due to severe
malaria (2),woundsepsis anddisruption(1)andahighfever
(1). Eight of the 11 HIV-uninfected women were admitted to
hospital before delivery with severe malaria (2), false labour
(2), preeclampsia (1), urinary tract infection (1), diarrhoea
(1), and psychosis (1). The three admissions after delivery in
these women were due to severe malaria (1), wound sepsis
and disruption (1), and postpartum haemorrhage (1).
Severe febrile illness was the commonest contributor to
major morbidity (Table 2), and was experienced by 34%
(44/129) and 24% (93/390) of the HIV infected and unin-
fectedwomenrespectively.Itoccurredmoreoftenafterdeliv-
ery in 89% (39/44) of the HIV-infected women and 84%
(78/93) of uninfected women. The crude odds ratio for se-
vere febrile illness after delivery among HIV-infected women
compared to uninfected women was 1.65 (95% conﬁdence
interval 1.05–2.60, P = 0.02). Severe febrile illness was less
common in women who had Caesarean section deliveries
(20/104,19%) than those delivered vaginally (117/381,31%)Journal of Pregnancy 3
Table 1: Characteristics of HIV-infected and uninfected women in the cohort study.
HIV infected
N = 132 (% or SD)
HIV uninfected
N = 399 (% or SD) P value
Sociodemographic characteristics
Private patients 16 (12) 46 (12) 1.0
Mean maternal age (standard deviation (SD)) 24.9 (3.8) 23.5 (3.7) 0.002
Nulliparous 56 (42) 250 (63) <0.001
4 or more antenatal visits in this pregnancy 94 (71) 273 (68) 0.6
Mean gestational age in weeks at recruitment
(standard deviation) 36.1 (1.9) 36.7 (1.3) <0.001
Highest level of formal education
Primary school or no formaleducation 36 (27) 79 (20)
Secondary school 58 (44) 165 (41) 0.02
Tertiary (higher) education 38 (29) 155 (39)
Women without own income 75 (57) 233 (58) 0.9
Married or cohabiting 102 (77) 341 (86) 0.04
Single 32 (23) 59 (14)
Place of delivery
St. Francis Hospital∗ 115 (87) 344 (86) 1.0
Home or other health care setting 16 (13) 50 (12)
Mode of delivery∗
Vaginal delivery 88 (77) 251 (79)
Elective Caesarean section 6 (5) 7 (2) 0.2
Emergency Caesarean section 20 (18) 65 (19)
Infant feeding practices 6 weeks after delivery∗∗
Exclusive breast feeding 75 (63) 299 (80)
Replacement feeding 39 (32) 8 (2) <0.001
Mixed feeding 6 (5) 68 (18)
∗Mode of delivery data only available for 459 births that occurred at St. Francis Hospital.
∗∗Infant feeding practices data only available for 120 and 375 births.
Table 2: Major morbidity in HIV-infected and uninfected women by 6 weeks after delivery.
HIV infected
N = 129 (%)
HIV uninfected
N = 390 (%) Crude odds ratio (95% CI) P value
Hospital admissions 6 (5) 11 (4) 1.68 (0.54–5.04) 0.31
Severe febrile illness 44 (34) 93 (24) 1.65 (1.05–2.60) 0.02
Surgical revision 3 (2) 7 (2) 1.30 (0.26–5.68) 0.71∗
Illnesses causing death 2 (2) 1 (0) 6.13 (0.43–172.02) 0.15∗
Major morbidity
(women with any of the above) 46 (36) 104 (27) 1.52 (0.97–2.38) 0.05
∗Fisher’s exact 2-tailed P value.
P = 0.03,andinwomenwhowerenotexclusivelybreastfeed-
ing(15/100,15%)thaninthosebreastfeeding(96/370,26%),
P = 0.03. Three HIV-infected women and 6 uninfected
women had surgical revisions of abdominal incisions; one
uninfected woman had an episiotomy resutured.
Three deaths occurred after delivery, two of which were
in HIV-infected mothers where the cause appeared AIDS
related: one with pneumonia and the other with a high fever
combined with vomiting and severe oral ulceration. The one
death of an HIV-uninfected mother was a primigravidae
woman who died from eclampsia and severe anaemia after
delivering twins. Unadjusted analyses of each potential con-
founding factor revealed higher odds for any major mor-
bidity among nulliparous women and women with no, or
minimal, formal education while women aged 25–29 years
seemed less likely to have major morbidity (not shown).
Whenpotential confounders(age,parity,private patients
versus general patients, employment status, and education)
were adjusted for, HIV status remained signiﬁcantly associ-
ated with major morbidity among women at 6 weeks after
delivery (Table 3), the adjusted odds ratio was 1.7 (95% CI
1.1 to 2.7), P = 0.02. Nulliparity (P = 0.003) and lack of or4 Journal of Pregnancy
Table 3: Major morbidity due to HIV infection adjusted for selected demographic factors.
N = 519 Adjusted odds ratio (95% CI) P value
HIV infection 129 1.7 (1.1–2.7) 0.02
Nulliparity 299 2.0 (1.3–3.0) 0.003
Private patients 60 0.9 (0.4–1.7) 0.64
Women without own income 300 0.8 (0.5–1.3) 0.33
Education
Tertiary education 110 Reference —
Secondary education 220 1.9 (1.1–3.1) 0.02
Primary or no education 189 2.1 (1.1–3.8) 0.02
Age
Age <20 years 68 Reference —
Age 20–24 236 1.1 (0.6–2.0) 0.77
Age 25–29 178 0.7 (0.4–1.5) 0.43
Age 30+ 37 0.7 (0.3–2.1) 0.57
minimal,formaleducation(P = 0.02)remained signiﬁcantly
associated with higher odds for major morbidity in these
adjusted analyses.
Baseline CD4 counts were available for 103 (80%) of the
129HIV-infected women who remained in follow-up. HIV-
infected women who had major morbidity had signiﬁcantly
lower CD4 counts than those that did not have any major
morbidity. The mean baseline CD4 count for the former
group was 312/uL (standard deviation 177/uL) while in the
lattergroupmeanCD4countwas456/ul(standard deviation
245/uL), P = 0.002. Major morbidity among HIV-infected
women stratiﬁed by WHO HIV clinical stage at recruitment
was 29/97 (30%) among women in WHO clinical stage I,
7/15 (58%) among women in WHO clinical stage II, and
10/16 (63%) among women in WHO clinical stage III, (chi-
square test for linear trend = 7.9, df = 1, P = 0.005).
4.Discussion
This cohort study estimated the odds of any major mor-
bidity to be 70% higher among HIV-infected women in
Uganda. The commonest major morbidity was severe febrile
illness, which occurred in 34% of HIV-infected and 24%
of uninfected women. These results are in line with what
has been found in other sub-Saharan African countries on
the impact of HIV on major maternal morbidity leading to
mortality [13, 14]. A ﬁve year audit in South Africa showed
thatmaternalmortality (meaning womenexperiencedmajor
morbidity) was 6-times higher among HIV-infected women
than infected women [15]. In Mozambique and Malawi,
HIV-related illness was the leading cause of death among
women who did not die of obstetric complications [16, 17].
HIV can aggravate other prevalent debilitating conditions
in pregnancy like anaemia, thereby increasing severity of
maternal morbidity [18, 19]. Similar ﬁndings have been
observedin developedcountrieswith HIV-infected pregnant
women having a higher risk of hospitalisation, and longer
stay during hospitalisation than HIV-uninfected women
despite the use of HAART [20, 21]. Our study quantiﬁed the
likelymagnitudeofthe deleteriouseﬀectofHIVonmaternal
morbidityinUganda,highlighting theneedfor interventions
to address maternal morbidity as PMTCT programs scale
up, even after HAART is widely available [21, 22]. In this
cohort study, HIV-infected women delivered by Caesarean
section had fewer severe febrile illnesses after delivery than
those deliveredvaginally. This ﬁnding iscontrary towhat has
been observed by others [23–25], but in our study women
who delivered by Caesarean section routinely had antibiotic
prophylaxis while those who delivered vaginally did not.
The strengths of this study lay in its prospective nature
and in having a comparison group of women who were not
infected with HIV. The same set ofstructured questionswere
used for both HIV-infected and uninfected women to limit
biased inquiry about and reporting of maternal morbidity
because HIV status of the mothers was generally known
to the interviewers. Some limitations of the study should
be noted: hospital admissions could overestimate major
morbidity if women are admitted for minor conditions [26],
but this was unlikely in our cohort where the ﬁnancial and
social costs of inpatient care are generally a deterrent to
admissions in this setting. Laboratory investigations were
limited in this study which meant that the study relied on
clinical features and maternal reports. However, the results
are applicable to resource-limited settings where many
patients are managed similarly. Finally, this study was not
designed or powered to examine maternal morbidity by ART
status or HIV disease stage, butthe stratiﬁed analysis implied
higher major maternal morbidity with more advanced HIV
disease. Further studies are needed to provide data on this
as the combination of maternal morbidity and HIV-related
morbidity can lead to a signiﬁcantly negative impact on
maternal health and survival. This study was limited to an
urban missionary hospital in the capitalcity so future studies
should include rural and government health facilities where
the impact of HIV on maternal morbidity could be higher.
5.Conclusion
HIVinfection increased the oddsofmajor maternal morbid-
ity by 70% in this cohort of Ugandan mothers giving birthJournal of Pregnancy 5
for the ﬁrst or second time. Maternal morbidity remains a
signiﬁcant health issue in such resource-limited settings and
there is need for more interventions to address the eﬀects of
HIV infection on maternal morbidity.
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